Ingredient Research Report · Version 1.0 · March 2026
Six ingredients. Fully disclosed doses. Every claim backed by published clinical evidence — no proprietary blends, no hidden fillers.
ZN·1 FOCUS is a precision-dosed nootropic performance pouch formulated with six research-backed ingredients. Each component has been selected based on published clinical evidence for its role in supporting cognitive function, sustained attention, and mental energy. This report summarises the scientific rationale, mechanism of action, and key clinical findings for each ingredient at the dosages used in the ZN·1 FOCUS formulation.
The formulation prioritises clean stimulation (paraxanthine over caffeine), synergistic stacking (L-Theanine for balanced focus), cholinergic support (Alpha GPC), adaptogenic resilience (Panax Ginseng), and essential cofactors for neurotransmitter synthesis (Vitamins B6 and B12). No proprietary blends are used — every dosage is fully disclosed.
| Ingredient | Dose | Primary Function |
|---|---|---|
| Enfinity® Paraxanthine | 100mg | Clean stimulation; sustained alertness without jitters |
| L-Theanine (Suntheanine®) | 100mg | Calm, focused attention; synergises with stimulants |
| Alpha GPC | 100mg | Cholinergic support; acetylcholine precursor |
| Panax Ginseng Extract | 100mg | Adaptogenic resilience; cognitive endurance |
| Vitamin B6 (P-5-P) | 10mg | Neurotransmitter synthesis cofactor |
| Vitamin B12 (Methylcobalamin) | 1mg | Nerve function; energy metabolism |
Ingredient Profiles
Paraxanthine is the primary active metabolite of caffeine, responsible for most of caffeine's alertness-promoting effects. Unlike caffeine, paraxanthine does not significantly affect adenosine A2A receptors associated with anxiety and cardiovascular stress. It selectively antagonises adenosine A1 receptors and inhibits phosphodiesterase, increasing intracellular cAMP and promoting wakefulness, reaction speed, and sustained vigilance — with a cleaner side-effect profile than caffeine.
In a double-blind, placebo-controlled crossover trial, acute ingestion of 100mg and 200mg paraxanthine improved measures of cognition, memory, reasoning, and response time while helping sustain attention. A separate study demonstrated that paraxanthine ingestion prior to a 10km run significantly improved prefrontal cortex function, attenuated attentional decline, and improved reaction time compared to placebo. Importantly, adding caffeine to paraxanthine provided no additional benefit, supporting paraxanthine as an independent nootropic. Seven-day repeated dosing showed no clinically significant side effects or adverse changes in blood markers.
L-Theanine is a non-proteinogenic amino acid found primarily in Camellia sinensis (tea). It crosses the blood-brain barrier and increases alpha-wave activity in the brain, promoting a state of relaxed alertness. L-Theanine modulates levels of GABA, serotonin, and dopamine, and is known to counterbalance the overstimulatory effects of stimulants — reducing jitters while preserving cognitive enhancement.
A randomised placebo-controlled study in middle-aged and older subjects found that L-Theanine reduced reaction time on attention tasks and increased correct answers in working memory assessments. A meta-analysis of five RCTs involving 148 healthy adults confirmed dose-dependent improvements in rapid visual information processing. The evidence is strongest in combination with stimulants: a study combining 97mg L-Theanine with 40mg caffeine significantly improved accuracy during task-switching and reduced self-reported tiredness. In the ZN·1 FOCUS formulation, L-Theanine is paired with paraxanthine to provide this synergistic effect.
Alpha GPC is the most bioavailable oral source of choline, a precursor to acetylcholine — the neurotransmitter most directly linked to learning, memory formation, and muscle contraction. Alpha GPC crosses the blood-brain barrier efficiently and raises both plasma and brain choline levels, supporting cholinergic neurotransmission. It also contributes to cell membrane phospholipid synthesis.
A 2024 randomised placebo-controlled study found that acute Alpha GPC supplementation significantly enhanced cognitive performance in healthy men, measured by improvements in Stroop test scores and completion times. A systematic review and meta-analysis of clinical trials confirmed that Alpha GPC enhances memory and cognitive function and provides greater and more sustained cognitive benefits than citicoline, another choline source. Alpha GPC has also been shown to increase motivation in a single-blind human study.
Panax Ginseng is an adaptogenic herb whose active compounds — ginsenosides — modulate the hypothalamic-pituitary-adrenal (HPA) axis, supporting the body's stress response while enhancing cognitive endurance. Ginsenosides interact with GABAergic, glutamatergic, and cholinergic systems, contributing to neuroprotection, improved cerebral circulation, and sustained mental performance under pressure. Standardised to 5% ginsenosides, HPLC verified.
A randomised, double-blind, placebo-controlled trial demonstrated that Panax Ginseng improved cognitive performance in subjects with mild cognitive impairment over six months, with particular benefits in visual memory. In healthy individuals, a 200mg dose significantly improved Serial Sevens subtraction task performance and reduced subjective mental fatigue during sustained mental activity. Current evidence supports ginseng as a cognitive enhancer especially under conditions of mental load and fatigue.
Vitamin B6 in its bioactive coenzyme form (P-5-P) is an essential cofactor in over 140 enzymatic reactions, including the synthesis of key neurotransmitters: serotonin (from 5-HTP), dopamine (from L-DOPA), GABA (from glutamate), norepinephrine, and histamine. P-5-P is the form directly usable by the body, bypassing hepatic conversion required by standard pyridoxine. It also plays a role in homocysteine metabolism, amino acid transport, and immune function.
Vitamin B6 deficiency is directly linked to neuropsychiatric symptoms including cognitive impairment, depression, seizures, and peripheral neuropathy. A high-dose supplementation study published in Human Psychopharmacology found that B6 significantly reduced anxiety and strengthened visual surround suppression, suggesting enhanced GABAergic inhibition. B6's role as a rate-limiting cofactor in neurotransmitter production makes it an essential inclusion in any nootropic formulation — ensuring the neurochemical pathways activated by other ingredients can function optimally.
Methylcobalamin is the neurologically active form of Vitamin B12. It serves as a cofactor for methionine synthase, which is critical for myelin synthesis, DNA methylation, and homocysteine clearance. Methylcobalamin promotes nerve cell survival, supports remyelination of damaged neurons, and facilitates neurite outgrowth through activation of Erk1/2 and Akt signalling pathways. Unlike cyanocobalamin, methylcobalamin does not require hepatic conversion and has superior retention in neural tissue.
A systematic review and meta-analysis confirmed that B12 supplementation is protective against neurological deterioration in deficient individuals. Research published in Frontiers in Pharmacology demonstrated that methylcobalamin enhances nerve repair and improves functional recovery after traumatic brain injury by inhibiting ER stress-induced neuron injury. A comprehensive review established that B12 holds a unique nerve-regenerating role, promoting remyelination and restoration of physiological nerve conduction velocity. In the ZN·1 FOCUS stack, methylcobalamin provides foundational neural support — ensuring optimal nerve conduction and energy metabolism.
Every ingredient above is in every FOCUS pouch. Fully dosed. No fillers. No compromises.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information in this report is provided for educational and informational purposes only and is not intended as medical advice. Consult a qualified healthcare professional before starting any supplement regimen. Clinical references are provided for informational transparency and do not constitute an endorsement of the cited research institutions.